rfhg_226917.1

Basic information about the TSS

---

TSS ID: rfhg_226917.1 Species: human Chr: chr21		Start: 44865707 End: 44865721 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS (EH38D3347638,EH38E2146409)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000474737.5:-175 GeneID: 754 HGNC/MGI_ID: HGNC:13524 UniProt_ID: Nearer transcript ids and distances:

Gene_name: PTTG1 interacting protein Gene_symbol: PTTG1IP Gene_synonyms: PBF PTTG1IP1 Gene_source: HGNC:13524

TATA-Box annotation

---

Distance to TSS:	7976
Nearest PromoterID:	NM_004339
Entrez ID:	754
Nearest Unigene:	Hs.474010
Nearest Refseq:	NM_004339
Nearest Ensembl:	ENSG00000183255
Gene Name:	PTTG1 interacting protein
Gene Alias:	C21orf1|C21orf3|PBF
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.533333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PTTG1IP p2@PTTG1IP p3@PTTG1IP p4@PTTG1IP
Sample		p1@PTTG1IP	p2@PTTG1IP	p3@PTTG1IP	p4@PTTG1IP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	79.48	21.62	1.75	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	81.13	25.29	2.02	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	77.16	31.06	3.09	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	74.02	30.77	2.91	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	83.91	25.65	2.70	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	76.56	27.52	4.07	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	96.52	23.75	2.18	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	71.45	26.40	1.45	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	75.44	24.58	2.35	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	70.13	26.08	2.32	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	65.89	34.76	2.02	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	63.83	34.56	2.85	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	144.11	18.54	4.03	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	133.96	20.90	3.46	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	124.05	17.13	1.98	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	131.03	18.11	4.78	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	135.85	27.52	4.80	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	119.37	22.36	5.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	108.76	14.40	3.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	118.25	17.90	4.06	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	137.53	24.19	3.74	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	131.19	20.54	4.66	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	135.59	21.33	4.14	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	133.95	21.11	2.91	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	141.64	25.28	4.64	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	134.52	20.57	4.11	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	121.98	21.43	4.95	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	160.31	25.46	4.72	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	131.16	21.32	3.07	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	157.98	26.60	4.89	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	150.10	27.21	5.02	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	155.52	25.79	5.47	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	146.45	24.90	3.59	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	152.40	32.49	3.63	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	148.47	29.17	3.55	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	156.36	29.32	3.83	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	165.14	32.70	4.70	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	147.29	25.99	3.63	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	166.11	30.25	5.67	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	153.64	29.77	4.80	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	151.51	27.29	5.18	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	157.96	30.60	5.42	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	153.32	31.00	2.95	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	165.21	32.52	4.55	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	167.44	29.92	5.62	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	166.11	28.85	6.75	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	169.61	33.83	6.48	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	158.26	31.59	5.96	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	187.91	30.40	6.94	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	136.69	29.93	5.46	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	164.78	37.92	5.94	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	197.47	48.70	7.12	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	419.77	125.93	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	212.56	48.97	4.97	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	205.46	45.07	5.63	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	251.68	49.50	7.55	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	153.39	42.71	6.89	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	246.97	59.64	11.99	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	228.99	50.10	7.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	190.48	46.84	8.80	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	233.37	60.63	7.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	222.07	52.71	10.65	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	177.54	39.01	4.78	10.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	215.41	46.21	7.14	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	262.86	66.93	13.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	272.98	76.68	7.10	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	436.43	129.31	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	529.13	197.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	205.73	49.24	4.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	190.41	41.16	5.95	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	194.68	42.69	7.04	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	180.50	32.13	6.62	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	207.88	37.43	4.64	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	217.08	34.85	5.50	0.92
Adipocyte - breast, donor1	11376-118A8	326.11	68.90	9.03	0.95
Adipocyte - breast, donor2	11327-117E4	309.30	72.51	7.86	3.53
Adipocyte - omental, donor1	11473-119C6	303.18	55.73	10.05	1.65
Adipocyte - omental, donor2	11474-119C7	363.28	87.46	12.71	2.24
Adipocyte - omental, donor3	11475-119C8	239.13	40.86	4.69	1.00
Adipocyte - perirenal, donor1	11476-119C9	426.82	130.79	16.59	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	127.54	19.79	2.20	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	144.07	15.81	3.61	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	106.35	6.43	1.56	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	179.73	27.38	3.72	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	161.38	37.32	3.86	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	172.28	32.62	3.62	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	119.33	24.10	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	138.26	17.13	2.82	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	164.60	29.69	5.81	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	138.63	15.46	2.67	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	96.82	11.69	2.78	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	111.46	16.22	2.50	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	128.35	16.83	3.27	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	137.12	17.67	5.24	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	82.21	9.74	1.83	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	221.22	40.66	8.18	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	108.65	13.98	3.59	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	154.54	21.56	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	162.81	15.47	2.70	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	160.66	13.39	6.69	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	157.17	14.59	2.88	0.82
Anulus Pulposus Cell, donor1	11248-116E6	212.15	25.86	4.69	0.92
Anulus Pulposus Cell, donor2	11463-119B5	183.44	24.49	4.41	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	199.04	41.78	5.39	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	201.44	53.40	5.21	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	196.90	40.66	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	193.70	43.34	3.29	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	192.23	46.79	6.32	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	172.28	40.26	2.64	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	175.44	44.18	4.55	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	204.37	54.85	3.40	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	182.32	45.73	7.72	3.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	199.24	46.33	7.16	3.77
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	201.01	37.74	8.71	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	157.98	40.12	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	234.09	50.57	5.77	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	195.17	60.05	4.09	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	185.02	39.05	4.98	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	209.49	55.72	5.36	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	193.66	40.24	4.72	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	205.81	44.90	6.15	4.01
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	206.80	54.63	5.85	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	193.06	43.12	5.97	2.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	212.53	48.03	10.81	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	261.97	53.10	10.62	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	203.78	46.83	5.49	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	151.02	54.53	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	216.98	58.25	7.77	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	214.01	55.40	5.69	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	175.65	46.03	12.11	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	204.64	58.14	5.70	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	211.21	51.31	7.70	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	198.73	44.39	5.42	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	202.23	56.77	6.57	4.69
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	192.29	40.52	6.75	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	191.92	49.23	7.13	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	192.45	43.29	4.09	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	214.66	49.68	5.12	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	173.45	43.96	7.13	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	224.78	51.36	6.61	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	215.98	49.41	5.09	4.33
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	176.63	39.39	6.99	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	189.44	61.28	3.45	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	186.28	40.01	5.08	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	172.54	35.67	4.35	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	200.28	49.13	3.78	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	184.61	42.55	5.76	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	222.37	41.69	9.27	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	242.95	54.93	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	196.83	49.31	4.07	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	206.37	47.53	6.62	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	180.06	60.51	3.64	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	195.17	43.22	3.68	3.45
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	216.78	66.31	2.55	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	188.39	39.41	6.86	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	214.08	48.51	6.40	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	191.86	42.84	5.81	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	201.24	59.27	6.21	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	199.57	48.78	4.21	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	175.47	44.25	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	168.38	39.33	6.65	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	201.77	41.57	3.71	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	181.36	41.07	4.72	1.09
Astrocyte - cerebellum, donor1	11500-119F6	266.51	69.02	8.72	0.98
Astrocyte - cerebellum, donor2	11580-120F5	249.89	56.31	9.24	2.05
Astrocyte - cerebellum, donor3	11661-122F5	197.16	33.77	6.08	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	208.80	32.42	4.88	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	178.60	33.97	4.85	2.91
Astrocyte - cerebral cortex, donor3	11392-118C6	204.65	33.86	7.16	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	54.93	7.91	1.03	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	46.23	9.27	0.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	47.34	8.08	0.57	0.23
Basophils, donor1	12241-129G9	134.95	57.54	3.14	0.52
Basophils, donor2	12242-129H1	87.67	28.14	1.80	0.00
Basophils, donor3	12243-129H2	84.52	34.99	2.94	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	95.51	9.27	1.29	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	52.58	3.20	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	60.25	6.90	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	87.13	6.86	2.29	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	89.35	6.45	0.69	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	69.10	4.68	0.72	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	29.58	4.23	0.62	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	44.95	4.66	1.16	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	99.45	31.66	1.60	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	31.03	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	95.24	41.70	4.51	0.00
CD14+ Monocytes, donor2	11305-117B9	71.64	33.96	4.83	1.30
CD14+ Monocytes, donor3	11381-118B4	72.45	23.49	2.20	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	174.92	19.25	4.25	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	171.72	15.16	4.55	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	191.66	24.98	2.96	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	128.79	45.39	4.91	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	82.38	29.57	3.32	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	104.71	40.98	4.50	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	85.37	33.81	2.85	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	47.47	16.56	2.76	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	55.29	21.07	1.49	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	58.54	18.21	1.76	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	46.11	13.89	1.42	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	59.20	24.16	0.87	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	50.34	15.69	1.87	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	48.05	20.07	1.58	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	47.70	23.30	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	81.07	30.79	4.16	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	64.45	26.34	2.79	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	80.57	28.52	1.87	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	89.91	37.98	4.80	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	64.02	29.63	1.81	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	69.83	29.24	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	83.92	23.40	1.88	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	70.66	21.98	2.09	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	79.96	32.40	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	101.04	38.58	5.70	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	62.35	29.24	2.82	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	95.20	43.00	5.70	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	44.12	11.16	0.87	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	42.00	9.29	2.23	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	51.95	18.54	1.72	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	90.09	37.26	6.96	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	66.76	28.74	1.85	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	106.72	51.04	3.71	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	88.71	28.12	2.40	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	96.32	28.18	2.54	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	80.80	30.98	1.95	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	130.03	41.58	4.36	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	119.63	40.69	2.79	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	140.25	47.27	3.34	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	75.79	16.59	1.79	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	74.87	24.59	3.73	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	94.32	20.42	1.68	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	8.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	61.02	6.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	48.67	9.32	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	49.04	6.93	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	50.39	6.97	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.14	6.32	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	40.79	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	56.69	6.59	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	21.37	2.47	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	21.76	7.25	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	25.24	6.06	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	85.26	18.18	2.83	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	68.31	11.98	1.20	0.80
CD34+ Progenitors, donor1	11545-120B6	70.28	30.12	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	95.51	39.33	4.49	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	78.91	35.70	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	89.97	31.79	1.80	0.23
CD4+ T Cells, donor1	11225-116C1	79.27	24.64	1.79	0.36
CD4+ T Cells, donor2	11306-117C1	62.46	19.60	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	59.78	31.41	2.13	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	59.21	8.42	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	80.86	11.68	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	75.89	11.79	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	39.82	7.59	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	47.76	11.24	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	81.51	20.09	0.72	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	79.99	9.83	1.86	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	73.83	9.67	0.97	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	63.21	18.38	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	73.02	23.76	1.40	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	66.00	18.92	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	52.71	12.65	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	69.81	12.26	0.21	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	64.82	12.36	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	57.11	10.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	83.07	16.61	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	7.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.91	17.62	0.56	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	71.27	13.21	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	75.23	10.72	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	48.54	9.10	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	54.16	14.30	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.07	8.28	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	99.96	13.36	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	65.55	12.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	48.85	8.37	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	95.26	19.94	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	100.61	20.86	0.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	115.50	21.56	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	100.27	19.34	1.07	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	88.64	15.23	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	64.50	28.16	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	46.18	18.40	3.00	2.63
CD8+ T Cells, donor3	11383-118B6	53.02	16.66	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.19	3.90	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.48	2.64	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.69	3.56	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	26.12	3.90	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.24	3.60	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.42	4.32	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	27.16	3.48	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.85	3.42	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	27.67	4.92	0.94	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	30.79	1.81	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.02	3.49	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	25.58	5.86	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	26.70	2.63	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.78	5.92	2.28	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	22.38	6.71	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	30.25	4.68	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.92	4.03	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	23.57	3.06	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.13	4.75	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	30.14	4.61	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.49	4.17	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.60	2.68	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.80	3.94	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	4.82	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	7.69	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	30.05	4.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	91.39	20.11	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	143.78	40.02	2.96	1.48
Cardiac Myocyte, donor3	11686-122I3	197.73	44.62	4.53	0.11
Chondrocyte - de diff, donor1	11261-116G1	316.16	74.19	6.93	2.43
Chondrocyte - de diff, donor2	11338-117F6	290.70	79.96	7.82	0.71
Chondrocyte - de diff, donor3	11410-118E6	358.52	88.06	13.54	4.10
Chondrocyte - re diff, donor2	11339-117F7	359.89	141.45	22.38	0.00
Chondrocyte - re diff, donor3	11411-118E7	380.95	114.04	20.62	6.07
Ciliary Epithelial Cells, donor1	11242-116D9	189.01	43.84	5.16	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	157.97	43.61	5.13	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	146.73	36.82	3.19	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	199.17	40.16	5.78	1.74
Corneal Epithelial Cells, donor1	11526-119I5	68.73	5.05	1.10	0.22
Corneal Epithelial Cells, donor2	11606-120I4	61.43	7.96	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	72.60	3.07	0.51	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	142.97	20.64	2.15	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	146.03	21.13	2.52	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	113.87	34.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	108.42	16.74	2.16	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	146.22	29.72	3.42	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	123.39	26.77	4.57	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	144.70	30.49	3.87	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	231.14	103.40	9.34	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	188.36	99.75	6.45	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	285.91	189.19	10.75	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	189.51	137.22	11.80	0.39
Endothelial Cells - Artery, donor1	11264-116G4	158.24	108.79	8.73	0.58
Endothelial Cells - Artery, donor2	11341-117F9	140.70	72.23	7.06	1.65
Endothelial Cells - Artery, donor3	11413-118E9	211.25	109.22	11.22	3.68
Endothelial Cells - Lymphatic, donor1	11236-116D3	175.33	77.58	6.65	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	216.33	85.19	7.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	217.35	104.87	8.46	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	232.06	132.22	9.21	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	170.26	89.03	7.81	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	184.32	87.20	9.22	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	233.27	115.63	15.20	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	275.17	164.58	16.25	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	208.98	95.92	11.93	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	144.04	69.96	12.38	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	150.83	70.22	8.79	0.49
Endothelial Cells - Vein, donor1	11267-116G7	160.39	103.51	10.24	0.00
Endothelial Cells - Vein, donor2	11344-117G3	195.58	141.10	12.57	0.00
Endothelial Cells - Vein, donor3	11416-118F3	194.69	86.20	11.93	1.10
Eosinophils, donor1	12244-129H3	76.23	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	318.50	166.68	4.95	0.00
Eosinophils, donor3	12246-129H5	370.95	164.07	14.27	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	90.16	9.53	1.47	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	72.81	10.40	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	284.90	63.22	10.26	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	145.73	27.92	4.05	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	40.95	10.83	3.79	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	213.57	47.54	4.61	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	121.46	19.52	2.73	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	183.83	33.22	4.64	1.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	400.51	89.06	6.06	3.95
Fibroblast - Aortic Adventitial, donor3	11401-118D6	184.04	28.24	5.98	2.99
Fibroblast - Cardiac, donor1	11268-116G8	203.68	61.24	6.35	1.81
Fibroblast - Cardiac, donor2	11345-117G4	165.99	44.72	9.10	0.00
Fibroblast - Cardiac, donor3	11417-118F4	196.04	53.62	5.99	0.95
Fibroblast - Cardiac, donor4	11452-119A3	146.40	19.40	3.33	0.00
Fibroblast - Cardiac, donor5	11456-119A7	191.50	44.92	6.22	2.16
Fibroblast - Cardiac, donor6	11460-119B2	148.11	32.90	7.58	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	246.81	50.25	6.16	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	125.98	39.26	5.61	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	134.76	17.58	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	171.36	28.37	2.54	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	206.75	25.10	4.07	0.34
Fibroblast - Dermal, donor1	11269-116G9	58.70	7.51	2.11	0.23
Fibroblast - Dermal, donor2	11346-117G5	115.56	32.07	3.30	0.00
Fibroblast - Dermal, donor3	11418-118F5	82.44	4.35	2.54	0.36
Fibroblast - Dermal, donor4	11450-119A1	82.98	7.35	1.92	0.68
Fibroblast - Dermal, donor5	11454-119A5	84.78	7.68	3.14	1.05
Fibroblast - Dermal, donor6	11458-119A9	93.07	9.42	2.27	0.97
Fibroblast - Gingival, donor1	11237-116D4	103.70	8.33	3.33	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	249.42	33.01	5.24	1.57
Fibroblast - Gingival, donor2	11318-117D4	189.24	19.77	4.22	2.64
Fibroblast - Gingival, donor3	11394-118C8	109.45	4.93	2.61	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	185.96	14.54	4.16	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	152.59	11.28	3.17	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	162.44	19.80	3.43	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	172.28	23.39	6.76	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	206.08	29.29	5.65	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	148.44	18.28	5.12	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	123.67	20.18	3.55	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	122.86	19.42	4.50	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	239.62	23.33	4.70	2.64
Fibroblast - Lung, donor1	11270-116H1	59.81	6.80	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	98.48	19.40	5.97	0.00
Fibroblast - Lung, donor3	11419-118F6	102.14	14.14	2.11	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	254.90	38.32	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	184.62	26.57	5.59	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	103.55	18.47	4.20	1.12
Fibroblast - Mammary, donor1	11540-120B1	181.87	23.14	4.06	0.00
Fibroblast - Mammary, donor2	11620-122A9	143.79	7.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	125.08	23.83	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	120.65	11.06	2.13	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	129.84	12.59	3.03	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	130.66	8.57	1.84	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	159.14	23.66	4.58	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	157.13	17.82	4.32	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	172.34	14.84	3.60	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	178.73	51.84	6.08	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	203.80	24.79	5.69	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	135.65	10.02	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	103.19	7.91	1.58	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	312.56	78.39	8.53	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	246.71	42.27	4.62	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	253.45	48.29	4.73	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	273.78	55.66	5.72	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	238.36	39.08	5.40	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	143.49	19.49	3.29	0.51
Fibroblast - skin normal, donor1	11553-120C5	292.06	43.32	6.40	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	341.46	53.33	7.22	1.40
Fibroblast - skin normal, donor2	11561-120D4	333.13	71.53	7.33	2.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	173.18	33.25	5.44	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	250.44	35.71	7.70	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	275.57	43.93	4.44	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	305.44	50.58	6.24	2.96
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	267.58	44.31	5.86	2.02
Fibroblast - skin walker warburg, donor1	11554-120C6	219.45	49.25	3.20	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	236.64	38.42	4.55	4.08
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	44.32	44.32	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	62.75	6.97	0.00	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	222.76	32.94	6.07	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	192.06	31.49	6.51	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	195.72	28.11	3.07	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	135.50	23.73	2.30	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	113.58	31.90	3.83	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	131.22	15.69	1.71	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	156.91	17.65	1.93	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	154.58	16.44	1.37	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	137.50	18.03	1.78	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	166.00	19.83	1.59	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	179.71	23.81	3.59	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	99.50	12.38	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	113.91	22.89	4.38	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	126.22	20.20	4.19	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	87.30	15.58	1.61	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	160.57	28.87	4.58	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	134.97	25.61	3.60	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	96.57	15.86	3.05	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	151.51	29.89	3.88	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	158.45	25.04	3.24	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	154.53	23.82	5.90	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	158.67	32.50	3.25	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	143.22	29.25	3.81	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	140.08	22.57	2.90	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	146.79	31.25	2.22	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	172.36	33.59	3.73	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	174.51	38.40	3.72	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	185.43	36.94	3.43	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	161.55	37.57	2.39	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	148.05	29.77	3.87	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	166.81	37.02	3.00	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	164.57	40.63	2.45	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	142.14	29.71	1.44	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	156.80	30.44	2.19	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	152.76	34.19	4.00	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	137.99	24.25	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	158.66	26.32	3.32	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	144.91	39.55	3.08	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	151.06	26.62	1.92	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	151.89	30.98	3.51	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	151.85	33.85	2.53	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	152.96	27.67	2.43	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	146.14	28.85	3.45	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	177.18	41.72	3.95	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	149.53	30.30	4.21	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	145.64	32.41	3.43	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	170.34	41.98	2.67	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	151.02	35.96	3.83	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	153.50	36.14	4.15	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	231.77	62.62	6.23	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	167.58	43.51	2.77	2.40
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	155.71	28.51	2.63	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	305.46	72.40	2.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	159.22	32.58	4.49	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	138.61	26.03	1.82	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	240.44	49.05	5.08	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	96.54	16.72	1.59	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	85.97	13.25	1.08	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	110.68	16.57	1.23	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	112.65	23.47	2.82	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	102.00	15.82	3.67	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	80.25	18.45	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	155.91	12.37	7.42	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	139.64	32.11	1.55	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	152.42	41.72	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	119.98	22.60	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	145.81	27.34	1.95	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	138.78	24.71	3.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	116.63	10.00	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	148.49	31.32	4.19	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	137.60	26.15	1.96	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	114.92	24.33	3.36	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	164.76	32.13	1.59	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	138.92	25.47	3.74	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	135.73	18.79	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	172.38	28.06	2.86	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	153.32	29.30	2.96	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	152.47	47.44	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	206.28	58.82	4.97	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	159.94	43.26	3.91	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	189.67	42.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	146.46	41.13	4.61	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	180.91	37.16	3.26	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	169.22	24.75	4.68	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	216.52	31.98	3.85	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	254.36	70.52	6.16	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	208.72	29.82	4.97	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	192.99	28.31	1.89	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	206.39	28.36	3.02	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	194.82	38.15	3.05	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	179.48	32.31	1.99	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	211.16	43.42	4.93	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	207.76	20.07	2.36	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	214.71	29.17	2.92	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	203.20	32.48	2.63	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	153.43	25.43	4.24	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	154.60	50.74	4.18	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	174.69	38.33	4.85	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	147.23	30.82	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	158.01	44.49	3.74	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	213.65	51.72	5.62	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	283.22	86.58	5.07	3.17
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	144.96	39.27	5.85	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	87.26	15.90	2.79	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	91.15	20.93	2.53	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	76.90	17.75	2.96	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	81.00	16.94	3.94	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	84.89	19.34	2.15	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	73.20	17.65	3.23	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	88.80	16.07	1.99	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	80.80	16.98	3.26	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	85.54	16.66	1.92	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	209.30	63.24	8.95	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	150.18	41.12	6.06	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	200.93	124.26	7.93	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	196.47	34.21	2.47	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	158.38	31.24	5.09	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	146.34	36.37	4.90	1.40
Hepatocyte, donor1	11523-119I2	184.01	26.63	3.63	1.21
Hepatocyte, donor2	11603-120I1	171.30	31.24	8.62	4.31
Hepatocyte, donor3	11684-122I1	147.86	19.63	5.52	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	54.17	6.53	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	310.76	41.77	2.10	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	214.45	58.31	6.31	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	51.22	11.08	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	10.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	61.72	8.12	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	41.68	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	68.98	21.78	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	58.23	5.29	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	39.91	5.54	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	45.35	14.49	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	4.64	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	47.81	5.17	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	43.47	8.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.89	7.33	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	36.10	4.20	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	47.42	6.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	47.09	7.39	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	55.23	11.80	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	54.42	4.53	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	44.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	45.20	6.46	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	43.20	7.62	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.25	7.65	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	7.29	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	43.56	3.57	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	16.59	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	57.72	9.57	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	14.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	62.86	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	8.34	2.09	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	6.64	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	64.84	9.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.03	9.59	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	9.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	13.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	46.94	10.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	59.84	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	7.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	12.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	42.29	12.69	4.23	0.00
Keratinocyte - epidermal, donor1	11272-116H3	135.78	19.75	2.86	0.57
Keratinocyte - epidermal, donor2	11349-117G8	84.33	7.61	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	69.38	2.46	1.04	0.28
Keratinocyte - oral, donor1	11251-116E9	124.19	9.19	1.82	0.68
Keratocytes, donor1	11527-119I6	181.20	29.57	4.47	1.72
Keratocytes, donor2	11607-120I5	147.65	26.95	1.17	0.00
Keratocytes, donor3	11688-122I5	86.94	11.86	1.78	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	312.10	37.36	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	155.34	45.31	6.47	4.31
Lens Epithelial Cells, donor2	11609-120I7	231.36	42.56	4.84	0.69
Lens Epithelial Cells, donor3	11690-122I7	240.57	60.85	4.64	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	207.39	96.76	10.08	1.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	156.28	81.77	9.21	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	242.57	127.66	11.49	5.04
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	155.94	81.73	9.14	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	157.27	94.23	9.14	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	196.65	100.48	9.60	3.13
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	135.84	77.97	5.34	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	156.24	86.21	6.07	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	184.95	100.64	9.85	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	121.82	56.96	4.75	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	156.46	75.61	4.65	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	178.85	97.76	10.18	2.59
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	149.82	73.52	5.23	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	170.31	79.43	6.20	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	182.81	104.80	9.34	2.61
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	137.35	77.61	4.93	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	138.10	73.88	5.92	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	208.43	115.65	10.98	2.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	130.00	74.38	7.24	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	160.20	91.38	4.98	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	187.69	112.02	11.70	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	135.79	80.02	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	131.15	74.33	4.04	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	193.91	113.08	9.84	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	130.12	76.21	8.29	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	160.60	79.57	3.77	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	199.09	101.05	9.32	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	128.63	76.35	4.82	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	144.50	69.05	4.33	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	184.17	95.74	9.54	2.76
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	144.40	71.23	7.75	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	146.87	79.72	5.62	1.98
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	189.93	97.13	9.79	3.35
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	158.08	85.52	6.66	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	141.83	75.85	3.21	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	165.68	91.30	6.74	2.20
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	147.95	85.88	5.47	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	151.86	65.43	6.09	2.74
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	187.41	100.36	11.62	3.50
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	140.80	66.49	7.11	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	132.34	72.72	5.33	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	170.86	87.14	8.09	2.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	143.96	71.26	7.88	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	134.59	69.91	4.57	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	183.63	98.17	9.18	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	186.99	91.70	6.68	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	127.81	57.88	2.82	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	150.67	95.47	5.67	2.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	197.14	13.60	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	180.28	29.15	2.30	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	144.73	25.98	2.97	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	173.48	23.70	5.08	4.65
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	162.47	18.99	2.81	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	148.50	27.09	5.60	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	142.21	29.89	5.15	6.18
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	157.01	27.36	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	181.63	24.43	4.98	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	180.89	34.03	4.94	4.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	185.02	32.86	3.15	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	205.13	30.62	4.74	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	180.25	28.76	2.05	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	196.54	30.70	3.88	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	148.59	35.31	6.66	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	186.44	26.49	2.04	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	190.50	28.55	2.67	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	193.10	32.12	3.02	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	181.61	27.00	5.52	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	189.99	30.17	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	201.79	32.90	6.66	4.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	208.23	32.23	6.45	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	187.52	29.88	2.06	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	206.41	32.51	4.35	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	185.04	31.69	7.47	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	199.73	34.30	4.98	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	188.06	28.28	4.24	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	192.87	30.24	5.90	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	165.78	33.39	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	185.35	29.17	2.69	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	193.62	30.00	6.23	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	196.09	27.08	4.92	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	163.58	25.76	5.42	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	187.44	32.32	6.46	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	195.69	35.85	6.72	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	197.32	32.33	6.69	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	202.02	31.01	6.89	3.45
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	208.08	27.40	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	200.57	35.98	6.00	4.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	219.60	39.22	5.43	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	172.06	31.28	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	190.08	23.72	3.09	4.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	190.55	26.30	5.37	4.83
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	171.03	31.65	2.69	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	191.87	30.74	4.82	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	190.72	33.72	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	156.55	32.79	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	192.47	27.61	5.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	145.37	24.71	5.09	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	184.73	26.06	6.13	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	159.33	22.20	3.45	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	132.67	25.41	6.59	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	178.00	23.13	5.03	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	174.39	26.14	2.70	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	139.41	39.59	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	173.68	25.38	2.23	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	182.22	34.80	1.96	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	157.68	32.99	3.96	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	169.69	22.31	4.15	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	201.72	24.94	4.38	6.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	187.86	21.25	3.91	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	193.88	25.17	4.42	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	190.54	23.53	5.40	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	176.21	26.84	1.52	5.06
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	184.56	37.97	3.84	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	207.52	32.60	2.39	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	195.05	27.34	3.04	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	145.26	20.75	4.84	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	183.16	32.68	4.56	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	170.42	28.40	5.68	4.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	163.86	33.26	2.42	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	193.63	35.18	4.44	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	165.79	29.32	2.13	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	139.07	26.43	5.17	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	181.52	28.80	4.63	5.66
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	188.86	30.42	7.07	3.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	179.89	28.37	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	186.80	23.30	4.58	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	195.76	39.94	7.05	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	168.69	22.13	4.18	3.76
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	174.70	28.34	3.25	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	166.59	28.10	8.70	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	208.51	32.61	5.88	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	200.43	26.27	4.45	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	183.55	30.29	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	172.49	32.90	3.56	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	197.17	34.19	2.85	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	186.36	32.98	5.37	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	175.10	44.87	6.57	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	209.36	36.53	5.35	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	255.54	40.03	6.24	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	206.89	40.45	5.30	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	191.23	35.34	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	187.35	30.31	3.42	0.46
Macrophage - monocyte derived, donor2	11313-117C8	117.63	12.11	1.47	0.73
Macrophage - monocyte derived, donor3	11389-118C3	148.25	22.68	3.54	1.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	190.11	40.36	7.97	1.06
Mallassez-derived cells, donor2	11929-125I3	454.44	122.96	12.83	1.58
Mallassez-derived cells, donor3	11930-125I4	208.06	40.86	4.59	0.83
Mammary Epithelial Cell, donor1	11273-116H4	127.24	16.84	1.89	0.70
Mammary Epithelial Cell, donor2	11350-117G9	94.68	9.56	2.03	0.29
Mammary Epithelial Cell, donor3	11422-118F9	81.06	13.97	1.75	0.50
Mast cell - stimulated, donor1	11487-119E2	88.81	16.95	1.36	0.00
Mast cell, donor1	11563-120D6	109.98	17.95	1.51	0.43
Mast cell, donor2	11565-120D8	219.02	57.35	3.27	1.19
Mast cell, donor3	11566-120D9	349.39	95.68	7.65	1.35
Mast cell, donor4	11567-120E1	204.77	46.45	4.25	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	109.34	12.53	0.44	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	71.79	10.51	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	123.56	13.42	0.92	1.15
Mast cell, expanded, donor8	11941-126A6	210.05	63.77	3.35	0.84
Melanocyte - dark, donor1	11502-119F8	215.91	87.96	6.77	0.70
Melanocyte - dark, donor2	11582-120F7	127.01	32.19	3.46	0.69
Melanocyte - dark, donor3	11663-122F7	304.54	65.78	5.07	0.07
Melanocyte - light, donor1	11274-116H5	154.68	26.09	3.06	0.24
Melanocyte - light, donor2	11351-117H1	305.74	85.31	11.60	1.36
Melanocyte - light, donor3	11423-118G1	98.86	21.68	5.20	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	249.38	41.13	5.83	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	229.68	52.17	7.53	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	391.34	144.37	12.05	2.68
Meningeal Cells, donor1	11493-119E8	295.01	93.04	11.66	0.99
Meningeal Cells, donor2	11573-120E7	299.30	80.55	11.00	0.88
Meningeal Cells, donor3	11654-122E7	196.26	62.51	8.64	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	163.39	28.52	3.14	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	403.53	138.47	13.59	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	44.68	2.63	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	56.25	5.23	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.81	5.02	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	170.90	19.91	3.18	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	155.32	17.59	3.52	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	145.48	20.00	3.52	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	189.95	47.49	5.11	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	127.26	15.35	3.27	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	170.50	18.56	3.46	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	129.36	21.19	2.23	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	168.81	21.84	3.03	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	105.94	18.40	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	63.06	9.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	137.69	11.53	2.56	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	88.97	9.92	1.77	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	158.86	13.13	2.19	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	108.13	21.05	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	174.49	20.68	3.18	0.27
Mesothelial Cells, donor2	12156-128G5	190.18	20.52	2.50	2.00
Mesothelial Cells, donor3	11402-118D7	179.72	21.75	3.97	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	87.77	10.80	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	129.29	14.04	1.97	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	100.70	10.31	4.12	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	103.71	6.91	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	96.39	17.36	2.17	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	81.73	7.88	1.87	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	60.22	11.58	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	120.88	13.01	3.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	98.22	9.78	1.40	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	105.47	12.80	2.03	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	89.09	6.73	2.77	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	76.10	11.50	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	100.30	7.22	1.90	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	65.80	2.63	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	93.59	15.49	3.61	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	69.98	12.89	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	91.50	14.31	2.09	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	40.24	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	89.57	18.57	2.76	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	75.10	10.22	2.85	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	51.97	8.85	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	79.90	11.97	1.38	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	84.77	10.73	1.68	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	76.23	9.17	1.63	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	80.88	14.37	2.36	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	74.02	7.78	2.67	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	30.96	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	65.92	11.83	1.75	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	50.19	7.60	3.04	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	64.62	6.63	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	66.32	13.05	2.17	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	82.34	8.53	1.47	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	55.61	13.08	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	63.91	11.53	2.88	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	77.24	9.21	1.60	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	52.11	8.23	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	61.57	14.52	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	63.19	6.12	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	91.09	14.89	3.94	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	54.08	11.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	81.33	17.29	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	80.57	17.35	3.72	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	67.50	8.35	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	132.59	28.73	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	137.09	31.79	3.42	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	66.96	12.25	1.75	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	134.23	28.41	6.04	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	142.24	37.59	3.93	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	99.34	17.04	3.33	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	120.05	23.89	5.24	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	138.46	34.99	3.62	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	104.77	19.62	2.50	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	132.07	35.10	3.69	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	98.46	22.76	2.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	132.10	24.73	3.18	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	134.76	26.95	4.66	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	112.39	18.87	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	105.44	17.79	2.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	128.91	32.56	4.54	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	151.16	24.84	3.59	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	111.45	23.45	3.53	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	139.19	26.76	6.69	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	126.93	20.12	2.65	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	111.11	20.48	4.17	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	137.51	32.10	4.55	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	132.73	17.70	2.46	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	101.01	20.20	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	122.32	29.40	2.65	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	139.55	17.88	3.17	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	177.22	28.44	5.36	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	149.49	25.01	4.47	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	139.37	22.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	115.85	23.17	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	178.74	29.57	2.96	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	137.81	19.99	5.26	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	135.61	18.78	3.95	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	192.78	34.46	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	169.36	30.04	2.63	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	113.20	14.12	2.13	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	150.99	23.07	3.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	137.77	18.42	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	156.83	20.89	6.23	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	116.67	14.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	121.32	17.10	4.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	135.24	30.91	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	162.60	23.23	3.03	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	77.58	11.81	2.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	5.45	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	42.60	11.44	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	40.49	12.15	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	34.74	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	17.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	19.01	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	195.40	39.21	3.23	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	177.69	36.06	5.23	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	99.46	15.35	4.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	95.58	17.95	5.43	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	112.18	20.35	2.09	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	255.34	47.88	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	97.91	20.40	3.40	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	161.71	23.89	11.03	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	96.26	14.23	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	131.56	19.76	2.79	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	102.69	9.46	1.35	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	180.17	40.37	6.10	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	33.40	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	115.65	18.37	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	87.70	11.10	3.79	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	100.87	9.75	2.95	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	99.78	16.33	3.76	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	181.34	36.82	5.29	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	143.22	29.70	4.24	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	137.47	27.01	4.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	77.45	13.46	1.97	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	100.01	11.22	3.42	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	194.02	45.15	7.58	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	148.38	34.46	5.63	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	143.89	23.45	4.14	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	131.43	18.32	3.86	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	96.91	15.86	2.41	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	171.93	30.34	7.59	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	167.31	29.41	4.68	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	147.34	30.48	6.35	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	124.37	19.70	3.32	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	167.41	20.17	6.44	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	216.67	54.17	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	114.63	14.00	3.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	169.98	37.87	3.16	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	142.45	33.33	6.35	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	155.08	24.14	5.57	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	150.21	16.65	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	133.29	25.09	3.58	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	91.95	9.59	4.36	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	209.86	43.87	5.43	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	125.23	29.10	4.41	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	154.24	25.93	5.98	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	126.99	18.35	2.48	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	106.81	15.31	4.59	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	180.56	22.99	2.12	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	194.94	45.75	7.74	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	145.70	39.30	8.13	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	270.81	56.20	10.22	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	157.91	16.46	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	133.76	17.00	1.89	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	100.78	10.29	2.42	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	212.03	44.30	3.96	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	177.98	26.07	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	197.26	40.46	15.17	10.12
Myoblast, donor1	11241-116D8	236.66	60.75	8.32	1.74
Myoblast, donor2	11322-117D8	191.60	41.23	6.33	3.64
Myoblast, donor3	11398-118D3	378.87	93.33	12.28	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	59.39	5.11	0.58	0.15
Natural Killer Cells, donor1	11230-116C6	70.73	29.83	2.77	0.92
Natural Killer Cells, donor2	11311-117C6	59.41	16.59	2.71	0.60
Natural Killer Cells, donor3	11387-118C1	64.05	23.01	0.74	0.55
Neural stem cells, donor1	11275-116H6	254.42	58.07	5.81	0.36
Neural stem cells, donor2	11352-117H2	142.50	36.59	5.78	0.00
Neurons, donor1	11494-119E9	187.75	56.89	5.69	0.00
Neurons, donor2	11574-120E8	122.19	21.58	3.08	0.66
Neurons, donor3	11655-122E8	174.30	37.00	9.87	0.82
Neutrophils, donor1	11233-116C9	124.35	44.54	3.71	0.93
Neutrophils, donor2	11314-117C9	156.54	40.58	0.00	5.80
Neutrophils, donor3	11390-118C4	308.48	51.92	5.50	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	273.57	33.60	6.29	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	134.15	17.91	4.56	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	114.31	9.63	2.01	0.80
Olfactory epithelial cells, donor1	11933-125I7	161.88	22.02	4.27	1.93
Olfactory epithelial cells, donor2	11934-125I8	163.71	14.76	4.63	3.18
Olfactory epithelial cells, donor3	11935-125I9	168.10	18.50	3.97	1.14
Olfactory epithelial cells, donor4	11936-126A1	189.54	20.26	4.48	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	250.36	31.90	5.42	1.81
Osteoblast - differentiated, donor1	11276-116H7	243.11	47.01	8.08	0.64
Osteoblast - differentiated, donor2	11353-117H3	206.90	44.58	5.72	0.00
Osteoblast - differentiated, donor3	11425-118G3	114.83	14.90	7.45	1.24
Osteoblast, donor1	11277-116H8	171.40	41.43	5.08	0.20
Osteoblast, donor2	11354-117H4	191.03	47.06	1.40	1.40
Osteoblast, donor3	11426-118G4	229.98	44.97	4.27	2.13
Pancreatic stromal cells, donor1	11249-116E7	128.88	12.80	1.85	0.93
Pericytes, donor1	11491-119E6	114.83	13.02	2.56	0.22
Pericytes, donor2	11571-120E5	150.76	30.33	4.30	0.91
Pericytes, donor3	11652-122E5	249.23	47.40	7.12	1.83
Perineurial Cells, donor1	11499-119F5	175.52	26.45	3.96	0.23
Perineurial Cells, donor2	11579-120F4	162.68	36.34	3.50	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	94.98	35.06	2.55	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	65.87	24.00	2.69	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	72.21	23.04	2.07	0.52
Placental Epithelial Cells, donor1	11278-116H9	145.65	16.74	2.15	0.24
Placental Epithelial Cells, donor2	11355-117H5	139.72	14.42	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	118.19	11.58	2.75	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	596.51	205.69	19.94	3.16
Preadipocyte - breast, donor1	11467-119B9	290.95	69.60	9.19	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	379.57	100.38	9.79	1.04
Preadipocyte - breast, donor2	11328-117E5	476.41	123.38	14.41	8.33
Preadipocyte - omental, donor1	11468-119C1	275.67	48.59	10.23	1.49
Preadipocyte - omental, donor2	11329-117E6	546.90	145.78	13.09	0.44
Preadipocyte - omental, donor3	11403-118D8	331.19	58.73	10.74	1.15
Preadipocyte - perirenal, donor1	11469-119C2	279.53	72.84	14.76	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	124.08	25.18	3.69	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	139.71	19.66	5.31	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	133.67	16.86	4.26	0.51
Preadipocyte - visceral, donor1	11280-116I2	142.42	17.79	3.54	0.65
Preadipocyte - visceral, donor2	11357-117H7	111.82	12.89	2.76	1.84
Preadipocyte - visceral, donor3	11429-118G7	115.25	16.72	4.91	1.67
Prostate Epithelial Cells (polarized), donor1	11253-116F2	235.93	33.64	2.87	3.17
Prostate Epithelial Cells, donor2	11331-117E8	142.32	22.61	4.33	1.35
Prostate Epithelial Cells, donor3	11404-118D9	69.32	4.04	0.92	0.49
Prostate Stromal Cells, donor1	11254-116F3	228.37	39.98	5.35	1.71
Prostate Stromal Cells, donor2	11332-117E9	157.60	24.56	4.30	1.61
Prostate Stromal Cells, donor3	11405-118E1	213.04	27.53	5.11	2.50
Renal Cortical Epithelial Cells, donor1	11516-119H4	252.20	62.78	6.93	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	192.83	35.76	6.10	1.66
Renal Epithelial Cells, donor1	11517-119H5	126.81	29.42	3.55	0.00
Renal Epithelial Cells, donor2	11597-120H4	232.60	74.69	7.82	2.85
Renal Epithelial Cells, donor3	11678-122H4	265.40	49.86	7.73	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	188.60	76.94	10.21	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	217.91	74.26	9.03	2.16
Renal Glomerular Endothelial Cells, donor3	11675-122H1	141.64	76.59	9.32	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	67.21	39.26	4.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	174.97	33.01	3.30	0.22
Renal Mesangial Cells, donor2	11598-120H5	228.22	47.65	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	134.54	19.70	3.05	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	309.76	107.91	11.01	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	232.77	76.75	5.48	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	205.57	53.42	5.79	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	148.83	17.11	2.59	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	423.52	115.12	9.66	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	113.20	25.73	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	180.65	39.64	8.03	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	287.85	37.42	3.88	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	270.70	50.03	6.25	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	200.89	41.28	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	222.16	63.81	4.64	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	286.71	56.95	5.72	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	279.05	46.87	6.36	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	309.97	60.34	7.14	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	384.53	72.57	7.57	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	291.48	58.86	6.29	4.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	320.12	54.32	9.71	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	257.25	48.33	4.38	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	264.73	49.01	6.66	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	323.08	60.03	8.06	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	281.17	59.68	7.17	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	280.09	53.23	7.30	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	281.01	52.44	5.75	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	234.96	55.63	5.93	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	270.17	48.63	7.36	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	333.91	66.33	7.70	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	264.35	55.74	7.30	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	290.47	56.46	7.11	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	287.20	53.66	7.64	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	263.99	56.71	6.73	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	277.50	57.46	5.33	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	296.51	56.57	7.18	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	261.64	59.80	5.29	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	269.30	53.71	6.62	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	309.20	60.31	6.31	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	291.77	69.58	8.96	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	281.55	56.55	9.33	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	294.88	64.54	7.02	4.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	278.89	61.38	9.54	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	300.62	73.66	9.29	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	271.76	54.31	6.48	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	285.18	61.10	8.21	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	263.62	57.56	5.96	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	267.41	52.63	7.52	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	271.15	65.85	7.22	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	258.15	59.26	7.82	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	265.79	51.88	8.70	5.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	235.36	50.28	6.48	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	295.91	50.75	5.77	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	258.02	44.78	6.40	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	211.27	37.33	4.56	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	259.06	42.62	5.95	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	323.88	61.87	7.86	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	266.80	59.14	5.27	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	282.63	54.50	7.34	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	224.85	45.94	4.84	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	314.90	73.68	6.24	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	292.71	64.19	6.55	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	322.47	83.35	11.56	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	300.19	79.87	8.14	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	426.82	93.87	11.31	4.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	357.05	82.07	7.19	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	409.36	96.47	5.90	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	390.82	89.22	6.62	4.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	308.30	64.91	4.81	3.61
Schwann Cells, donor1	11498-119F4	151.40	19.56	5.27	0.94
Schwann Cells, donor2	11578-120F3	88.46	44.23	0.00	0.00
Schwann Cells, donor3	11659-122F3	138.68	24.98	4.16	0.44
Sebocyte, donor1	11220-116B5	165.97	10.41	0.00	1.10
Sebocyte, donor2	11301-117B5	86.86	11.49	2.30	0.46
Sebocyte, donor3	11378-118B1	73.17	7.01	1.86	0.82
Sertoli Cells, donor1	11255-116F4	385.99	99.40	4.97	0.00
Sertoli Cells, donor2	11333-117F1	344.57	98.85	11.30	2.82
Skeletal Muscle Cells, donor1	11281-116I3	174.90	35.37	4.05	0.44
Skeletal Muscle Cells, donor2	11358-117H8	129.39	18.07	2.17	2.17
Skeletal Muscle Cells, donor3	11430-118G8	170.55	31.77	5.85	4.18
Skeletal Muscle Cells, donor4	11451-119A2	90.49	11.62	2.98	2.04
Skeletal Muscle Cells, donor5	11455-119A6	87.25	12.93	2.23	0.59
Skeletal Muscle Cells, donor6	11459-119B1	119.12	25.86	4.77	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	129.03	15.12	2.39	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	101.88	10.13	2.71	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	124.11	25.50	3.57	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	186.70	41.79	4.21	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	176.60	27.50	6.51	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	156.86	31.23	4.82	2.89
Skin - palm, donor1	10286-104F7	112.82	37.61	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	108.41	17.01	3.32	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	65.43	15.54	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	82.44	14.28	2.34	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	159.03	23.63	5.14	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	141.22	22.36	3.38	1.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	119.04	15.22	2.33	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	117.67	13.57	2.62	1.27
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	49.68	15.12	5.86	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	396.86	84.49	8.23	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	182.23	24.10	7.05	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	147.40	25.86	3.98	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	209.49	31.11	5.51	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	182.33	33.22	3.09	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	128.10	20.02	4.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	198.95	42.05	8.12	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	136.10	19.73	4.21	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	265.41	58.38	11.14	4.10
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	159.21	26.37	4.23	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	142.64	23.63	3.25	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	139.94	29.61	3.70	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	106.23	10.41	3.74	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	91.03	10.96	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	179.83	26.01	5.05	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	85.69	24.48	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	116.35	30.99	6.20	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	105.30	9.88	3.24	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	99.44	15.93	2.58	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	105.80	12.80	3.15	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	200.00	36.50	6.19	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	252.22	59.28	16.17	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	136.88	19.13	6.28	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	152.61	24.92	4.78	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	155.96	16.02	2.36	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	159.92	23.75	3.93	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	321.08	100.58	12.29	4.32
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	285.60	62.19	4.83	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	132.46	21.46	1.59	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	160.59	22.77	3.73	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	205.61	37.57	5.89	2.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	120.49	13.70	3.04	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	185.30	33.92	7.84	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	163.54	27.01	6.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	202.88	78.83	3.88	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	175.33	27.90	4.19	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	182.26	41.91	5.55	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	166.73	31.65	6.58	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	123.31	13.86	3.83	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	126.96	16.58	3.25	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	99.97	10.28	2.34	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	223.94	59.15	5.47	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	194.79	55.33	8.67	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	219.62	64.87	8.09	3.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	177.48	29.35	4.19	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	201.26	28.66	3.85	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	48.57	3.33	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	212.37	55.78	7.34	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	168.36	28.06	5.74	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	62.90	4.68	1.46	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	117.01	15.35	2.92	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	83.83	14.28	1.32	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	65.09	8.55	1.86	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	163.50	26.23	3.59	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	100.50	15.61	4.83	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	173.70	46.08	5.12	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	106.91	19.05	2.54	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	124.99	17.57	2.40	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	101.99	10.45	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	169.14	21.54	7.33	0.92
Synoviocyte, donor1	11291-117A4	263.42	63.46	6.90	1.51
Synoviocyte, donor2	11368-117I9	273.56	51.13	9.22	1.68
Synoviocyte, donor3	11440-118H9	206.88	32.62	4.69	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	246.92	51.81	2.86	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	85.23	17.84	9.91	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	132.91	18.76	4.40	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	97.13	6.09	1.43	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	64.17	5.80	1.55	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	77.31	5.73	2.86	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	276.93	38.01	4.55	1.35
Urethra, donor2	10319-105A4	156.46	21.58	3.60	3.60
Urothelial Cells, donor1	11520-119H8	136.02	13.55	3.45	0.53
Urothelial Cells, donor2	11600-120H7	100.14	7.61	2.40	1.20
Urothelial Cells, donor3	11681-122H7	99.02	5.50	1.15	1.15
Urothelial cells, donor0	11216-116B1	187.90	8.69	2.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	181.52	57.84	3.56	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	213.01	35.74	8.58	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	147.17	30.12	2.74	6.16
Whole blood (ribopure), donor090325, donation1	12176-128I7	108.12	32.71	1.38	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	129.57	31.38	1.16	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	222.83	62.47	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	202.83	54.15	4.59	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	125.98	31.95	2.74	4.56
Wilms' tumor cell line:G-401	10809-111A8	99.55	17.52	2.96	0.62
Wilms' tumor cell line:HFWT	10597-108E3	90.64	7.92	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	85.47	6.42	1.12	0.28
achilles tendon, donor2	10292-104G4	51.66	16.53	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	42.32	6.37	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	23.91	5.57	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	69.21	10.09	0.59	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	120.00	21.77	2.72	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	85.45	21.64	1.12	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	158.19	63.23	3.81	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	232.74	89.01	3.81	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	98.70	28.64	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	262.17	69.83	5.72	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	145.22	41.94	5.82	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	59.80	14.35	1.10	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	108.06	35.32	2.79	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	55.40	11.91	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	55.82	14.32	2.63	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	63.67	16.73	2.32	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.08	16.86	3.29	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	48.81	8.59	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	69.98	8.53	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	72.79	10.01	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	71.49	13.96	2.17	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	55.68	17.15	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	45.03	9.01	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	70.61	13.01	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	127.31	48.59	4.14	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	208.91	88.97	5.23	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	151.83	41.24	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	105.74	11.07	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	150.00	27.92	2.33	0.31
adipose, donor1	10184-103D4	194.10	22.28	0.59	2.93
adipose, donor2	10185-103D5	133.01	16.22	1.22	0.81
adipose, donor3	10186-103D6	142.68	23.14	2.45	1.09
adipose, donor4	10187-103D7	122.21	15.60	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	116.63	6.63	3.79	0.16
adrenal gland, adult, pool1	10081-102A9	83.67	29.10	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.96	7.20	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	262.97	55.02	11.43	0.36
amniotic membrane cells, donor1	12235-129G3	236.02	21.10	6.49	0.93
amniotic membrane cells, donor2	12236-129G4	209.29	17.92	3.72	0.68
amniotic membrane cells, donor3	12237-129G5	212.41	12.37	1.47	1.77
amygdala - adult, donor10196	10167-103B5	106.72	26.09	0.00	0.00
amygdala, adult, donor10252	10151-102I7	220.81	30.62	5.47	2.84
amygdala, newborn, donor10223	10360-105E9	127.82	22.59	4.52	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	164.00	40.62	3.95	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	91.56	24.27	2.65	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	111.57	11.69	1.00	0.00
aorta, adult, pool1	10052-101G7	243.20	33.15	2.94	2.35
appendix, adult	10189-103D9	104.40	19.41	2.33	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	117.63	13.41	2.41	0.69
artery, adult	10190-103E1	107.34	16.30	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	241.35	37.96	4.49	0.43
b cell line:RPMI1788	10427-106D4	54.42	5.95	0.74	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	337.10	87.12	9.71	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	376.78	118.09	14.69	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	146.29	23.43	1.67	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	85.56	30.76	2.24	0.00
bladder, adult, pool1	10011-101C2	162.96	21.08	2.82	1.30
blood, adult, pool1	10053-101G8	84.16	22.15	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	414.47	148.15	15.41	0.00
bone marrow, adult	10192-103E3	149.14	37.79	3.37	6.07
brain, adult, donor1	10084-102B3	84.06	16.40	3.08	0.00
brain, adult, pool1	10012-101C3	113.81	18.93	3.23	0.89
brain, fetal, pool1	10085-102B4	160.28	21.37	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	159.24	15.86	4.63	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	104.48	6.74	1.62	0.12
breast, adult, donor1	10080-102A8	155.95	10.10	1.26	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	68.85	6.35	1.14	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	178.42	44.84	3.09	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	59.63	3.22	0.92	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	81.83	15.25	1.69	0.00
carcinoid cell line:NCI-H1770	10703-109H1	78.99	8.93	0.47	1.88
carcinoid cell line:NCI-H727	10735-110B6	121.63	27.78	1.31	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	88.41	12.68	1.90	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	103.81	12.78	2.40	1.86
caudate nucleus - adult, donor10196	10177-103C6	158.88	31.09	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	146.24	19.58	3.68	1.84
caudate nucleus, adult, donor10258	10379-105H1	115.38	9.93	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	150.16	19.41	4.76	0.37
cerebellum - adult, donor10196	10173-103C2	128.18	26.22	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	136.86	16.87	2.35	1.92
cerebellum, adult, pool1	10083-102B2	75.54	7.93	3.45	1.38
cerebellum, newborn, donor10223	10357-105E6	156.92	27.40	4.98	2.49
cerebral meninges, adult	10188-103D8	97.33	12.61	3.78	0.76
cerebrospinal fluid, donor2	10294-104G6	58.47	10.23	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	126.10	22.14	1.58	0.14
cervical cancer cell line:ME-180	10553-107I4	87.17	9.11	1.16	0.00
cervix, adult, pool1	10013-101C4	180.06	32.02	3.04	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	319.92	48.49	6.69	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	245.58	31.35	7.84	2.61
choriocarcinoma cell line:BeWo	10423-106C9	97.31	10.44	1.12	0.62
choriocarcinoma cell line:SCH	10785-110H2	124.81	14.05	4.31	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	174.80	22.77	2.61	0.71
chorionic membrane cells, donor1	12238-129G6	209.70	20.23	2.56	0.85
chorionic membrane cells, donor2	12239-129G7	282.88	27.54	4.37	1.09
chorionic membrane cells, donor3	12240-129G8	261.01	35.17	6.04	4.95
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	60.59	16.16	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	104.12	36.11	3.07	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	95.67	25.34	2.32	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	56.50	11.04	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	70.39	10.88	1.45	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	59.25	13.23	1.22	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	76.26	8.54	0.88	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	103.73	37.53	2.61	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	116.81	10.06	3.89	3.20
clear cell carcinoma cell line:TEN	10636-108I6	247.42	78.25	5.38	0.87
colon carcinoma cell line:CACO-2	10513-107D9	289.21	46.86	6.04	0.92
colon carcinoma cell line:COLO-320	10420-106C6	78.30	7.22	0.38	0.38
colon, adult, donor1	10082-102B1	174.93	19.04	3.57	0.00
colon, adult, pool1	10014-101C5	180.25	25.50	2.94	0.82
colon, fetal, donor1	10070-101I7	273.15	53.15	4.33	2.47
common myeloid progenitor CMP, donor1	12130-128D6	123.76	32.08	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	275.40	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	36.54	7.65	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.36	5.13	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	37.65	4.51	0.85	0.14
corpus callosum, adult, pool1	10042-101F6	296.75	30.18	6.08	0.88
cruciate ligament, donor2	10295-104G7	75.37	22.69	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	109.95	9.63	0.80	0.00
diencephalon, adult	10193-103E4	121.43	14.40	3.60	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	24.80	5.74	0.23	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	135.14	15.13	2.31	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	210.39	32.98	5.54	1.20
ductus deferens, adult	10196-103E7	112.13	17.94	1.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	164.19	24.48	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	194.95	38.25	2.94	3.68
dura mater, adult, donor1	10041-101F5	248.92	62.11	7.43	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	127.69	48.41	4.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	175.10	31.81	5.59	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	158.47	20.96	8.02	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	134.10	15.14	4.24	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	137.70	18.52	4.63	0.93
embryonic pancreas cell line:2C6	10603-108E9	132.66	28.90	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	252.74	40.22	7.04	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	203.35	18.67	4.35	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	164.19	27.34	4.66	1.77
epidermoid carcinoma cell line:A431	10426-106D3	133.39	21.68	3.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	240.76	79.85	8.47	1.21
epididymis, adult	10197-103E8	168.08	37.05	5.23	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	538.62	170.49	31.40	3.37
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	126.23	35.39	4.33	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	136.03	26.87	3.01	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	140.84	30.31	3.25	1.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	139.92	26.55	3.58	1.34
esophagus, adult, pool1	10015-101C6	122.32	13.59	2.02	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	93.43	2.88	0.88	0.00
eye - muscle inferior rectus, donor1	10272-104E2	89.34	24.15	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	63.13	14.73	0.00	0.00
eye - muscle medial, donor2	10299-104H2	75.90	5.95	4.46	0.00
eye - muscle superior, donor2	10297-104G9	56.18	8.03	2.29	2.29
eye - vitreous humor, donor1	10268-104D7	56.84	11.66	2.91	1.46
eye, fetal, donor1	10054-101G9	143.90	31.02	2.54	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	164.64	46.80	4.49	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	111.59	17.57	3.56	0.71
frontal lobe, adult, pool1	10040-101F4	96.45	12.85	1.88	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	132.11	16.21	3.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	201.89	26.06	3.66	0.46
gall bladder, adult	10198-103E9	181.07	28.01	3.62	2.66
gamma delta positive T cells, donor1	11937-126A2	67.11	13.42	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	79.18	21.66	1.87	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	436.37	140.88	14.36	4.44
gastric adenocarcinoma cell line:MKN45	10612-108F9	135.78	17.79	1.55	0.19
gastric cancer cell line:AZ521	10549-107H9	154.94	15.74	2.62	0.00
gastric cancer cell line:GSS	10560-108A2	264.50	29.29	3.66	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	108.75	19.19	0.91	1.83
giant cell carcinoma cell line:LU65	10487-107B1	131.95	16.18	1.95	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	108.47	8.96	1.82	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	151.40	15.21	2.24	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	253.01	39.79	4.86	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	239.03	33.99	4.92	0.70
glioblastoma cell line:T98G	10485-107A8	178.14	24.61	2.76	0.88
glioma cell line:GI-1	10413-106B8	178.66	22.84	3.81	0.59
globus pallidus - adult, donor10196	10175-103C4	153.07	24.78	5.83	0.00
globus pallidus, adult, donor10252	10161-103A8	289.01	45.40	6.10	3.42
globus pallidus, adult, donor10258	10367-105F7	201.27	17.80	5.48	2.74
globus pallidus, newborn, donor10223	10364-105F4	220.09	51.69	7.99	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	97.89	19.58	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	109.76	57.49	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	181.44	32.64	4.16	2.24
hIPS +CCl2, biol_rep1	14383-156B9	76.21	13.77	2.30	0.00
hIPS +CCl2, biol_rep2	14384-156C1	87.79	20.58	0.91	0.91
hIPS +CCl2, biol_rep3	14385-156C2	101.12	16.75	0.64	0.00
hIPS, biol_rep1	14380-156B6	67.55	21.56	1.44	0.00
hIPS, biol_rep2	14381-156B7	68.59	17.15	4.12	0.00
hIPS, biol_rep3	14382-156B8	122.48	18.76	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	45.97	5.75	0.86	0.00
heart - mitral valve, adult	10205-103F7	131.25	24.22	3.29	1.49
heart - pulmonic valve, adult	10206-103F8	122.63	16.21	2.88	1.83
heart - tricuspid valve, adult	10207-103F9	154.04	48.29	3.33	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	176.71	19.59	3.47	2.45
heart, adult, diseased, donor1	10051-101G6	218.45	24.70	5.11	3.41
heart, adult, pool1	10016-101C7	159.60	21.62	1.84	0.23
heart, fetal, pool1	10046-101G1	275.18	43.64	3.59	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	208.87	24.99	3.09	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	244.97	52.32	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	279.11	68.29	7.85	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	270.79	58.99	8.62	4.01
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	302.76	72.25	7.28	3.03
hepatoma cell line:Li-7	10484-107A7	116.44	13.68	1.22	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.48	11.36	0.50	0.00
hippocampus - adult, donor10196	10169-103B7	119.24	21.77	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	284.11	33.68	5.10	4.08
hippocampus, adult, donor10258	10374-105G5	72.20	15.44	2.49	0.50
hippocampus, newborn, donor10223	10363-105F3	111.74	21.85	2.82	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	136.11	26.86	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	108.19	16.30	1.96	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	108.16	17.26	3.05	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	140.40	16.35	2.82	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	141.50	12.91	1.81	3.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	169.31	15.94	1.90	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	144.52	27.44	2.34	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	154.89	17.45	5.17	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	164.33	30.03	3.75	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	167.18	41.20	4.50	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	167.47	42.11	3.21	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	166.31	32.99	2.69	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	86.69	11.89	1.56	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	82.05	13.76	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	79.42	20.07	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	175.64	25.20	2.29	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	154.37	21.80	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	134.44	18.49	1.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	152.79	19.03	3.20	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	143.24	25.92	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	140.96	21.61	4.39	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	166.73	42.79	1.80	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	161.12	38.90	3.77	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	154.54	36.77	3.59	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	175.88	25.31	2.96	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	172.31	27.67	3.42	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	189.86	31.44	4.08	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	258.08	39.43	6.34	4.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	222.35	31.99	3.80	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	236.65	39.64	5.14	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	239.43	33.10	5.17	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	221.83	47.16	5.98	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	212.41	42.33	4.36	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	277.63	61.61	6.65	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	339.99	73.45	9.84	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	270.53	68.89	7.73	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	167.12	22.46	2.90	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	151.08	28.08	0.89	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	182.93	35.61	2.44	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	262.22	33.31	3.06	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	605.10	78.08	13.01	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	245.56	33.43	3.31	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	244.10	37.22	5.47	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	218.58	35.10	1.81	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	181.49	27.05	7.12	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	247.03	91.89	5.97	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	313.10	80.98	5.96	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	216.86	53.07	4.58	0.81
immature langerhans cells, donor1	11904-125F5	233.91	123.49	15.74	0.73
immature langerhans cells, donor2	11905-125F6	94.26	44.36	8.71	0.79
insula, adult, pool1	10039-101F3	109.40	13.53	2.27	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	89.09	4.88	0.98	0.33
kidney, adult, pool1	10017-101C8	253.52	62.48	5.41	0.80
kidney, fetal, pool1	10045-101F9	256.49	59.84	6.30	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	193.72	38.63	4.69	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	62.35	11.61	1.11	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	155.42	24.59	3.85	0.73
left atrium, adult, donor1	10079-102A7	139.48	13.08	2.72	1.09
left ventricle, adult, donor1	10078-102A6	158.27	19.21	2.02	1.52
leiomyoblastoma cell line:G-402	10721-110A1	71.14	5.47	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	332.66	56.76	9.70	7.54
leiomyoma cell line:15242A	10570-108B3	268.48	44.57	11.41	3.26
leiomyoma cell line:15425	10571-108B4	191.58	19.18	5.83	6.31
leiomyosarcoma cell line:Hs 5.T	10722-110A2	292.07	25.40	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	286.48	56.46	13.59	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	102.12	58.91	3.19	0.59
liposarcoma cell line:KMLS-1	10782-110G8	150.43	14.68	2.97	0.94
liposarcoma cell line:SW 872	10726-110A6	227.84	43.86	5.85	0.61
liver, adult, pool1	10018-101C9	205.17	22.69	4.54	0.81
liver, fetal, pool1	10086-102B5	84.66	10.35	2.82	0.00
locus coeruleus - adult, donor10196	10182-103D2	137.22	22.60	7.44	0.73
locus coeruleus, adult, donor10252	10165-103B3	199.68	20.30	5.91	1.66
locus coeruleus, adult, donor10258	10375-105G6	178.88	18.34	7.05	1.41
locus coeruleus, newborn, donor10223	10362-105F2	219.56	38.70	2.94	2.10
lung adenocarcinoma cell line:A549	10499-107C4	75.15	4.01	0.69	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	84.11	13.10	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	235.03	55.76	3.82	0.79
lung, adult, pool1	10019-101D1	199.16	32.96	3.66	0.24
lung, fetal, donor1	10068-101I5	252.87	61.08	7.42	0.29
lung, right lower lobe, adult, donor1	10075-102A3	194.74	39.41	3.67	2.29
lymph node, adult, donor1	10077-102A5	98.46	23.67	4.26	2.37
lymphangiectasia cell line:DS-1	10727-110A7	51.07	8.55	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	29.88	1.36	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	194.53	46.72	3.40	0.00
mature adipocyte, donor1	12231-129F8	68.37	8.88	0.00	0.00
mature adipocyte, donor2	12232-129F9	77.20	7.47	1.66	0.83
mature adipocyte, donor3	12233-129G1	75.62	6.64	1.66	0.71
mature adipocyte, donor4	12234-129G2	79.49	7.90	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	189.89	39.79	3.57	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	71.07	15.79	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	162.57	20.41	3.68	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	78.79	13.98	2.22	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	80.18	21.75	2.99	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	82.86	14.51	2.19	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	166.38	23.34	3.61	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	59.71	13.48	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	74.66	12.56	2.15	0.00
medulla oblongata - adult, donor10196	10174-103C3	168.73	31.80	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	235.92	26.32	6.66	1.86
medulla oblongata, adult, pool1	10038-101F2	220.31	37.14	5.06	0.82
medulla oblongata, newborn, donor10223	10361-105F1	232.96	34.37	7.99	1.04
medulloblastoma cell line:D283 Med	10838-111E1	63.77	7.53	0.89	0.66
medulloblastoma cell line:ONS-76	10759-110E3	154.43	33.99	5.87	0.49
melanoma cell line:COLO 679	10514-107E1	509.87	232.15	13.22	2.16
melanoma cell line:G-361	10465-106H6	159.08	20.63	2.99	0.27
meningioma cell line:HKBMM	10691-109F7	178.91	45.23	4.70	4.88
merkel cell carcinoma cell line:MKL-1	10843-111E6	99.57	16.74	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	98.76	16.85	1.04	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	133.79	16.88	2.92	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	120.16	12.72	1.27	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	117.61	28.57	2.48	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	166.46	22.62	2.81	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	133.26	22.53	6.16	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	136.73	15.27	7.63	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	149.49	15.62	5.15	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	115.59	14.61	3.45	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	105.18	13.53	3.32	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	131.39	15.39	3.65	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	177.69	24.61	6.54	1.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	121.53	13.50	4.61	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	116.79	22.14	2.77	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	157.44	12.92	6.28	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	143.94	18.17	2.45	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	144.50	28.76	5.39	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	118.55	8.59	2.38	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	148.65	30.09	3.65	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	182.09	36.08	4.62	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	103.41	10.16	1.79	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	150.11	30.99	5.34	1.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	163.83	14.73	4.42	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	163.68	22.03	4.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	701.41	221.87	28.63	13.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	133.80	13.70	5.94	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	131.22	19.95	4.09	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	149.46	26.44	2.36	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	128.16	21.57	3.70	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	116.97	20.71	3.77	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	139.11	20.31	4.06	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	115.93	27.51	4.72	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	127.89	21.78	5.56	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	155.75	25.96	6.06	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	139.44	22.53	4.02	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	137.24	18.03	4.09	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	134.93	21.27	2.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	131.24	23.83	3.69	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	124.04	22.93	5.73	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	128.44	21.05	3.01	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	172.27	24.61	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	123.96	36.15	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	136.09	30.21	6.50	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	154.23	20.37	4.36	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	172.72	28.25	6.93	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	138.20	13.08	5.72	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	142.66	24.49	5.05	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	151.11	27.28	10.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	136.11	30.80	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	185.92	14.30	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	147.65	26.09	5.34	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	170.58	26.81	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	148.84	29.14	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	146.24	21.73	2.41	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	150.44	17.19	6.45	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	127.74	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	127.42	10.33	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	119.39	14.26	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	139.03	18.27	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	94.91	15.33	2.36	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	103.80	17.77	3.43	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	105.60	18.71	6.68	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	96.98	11.83	8.28	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	77.04	20.54	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	95.69	17.21	4.13	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	93.52	11.88	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	78.51	11.22	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	107.49	10.18	4.45	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	107.19	14.51	3.22	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	135.20	13.08	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	116.57	16.47	2.53	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	87.39	13.35	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	112.97	13.56	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	87.31	9.06	2.47	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	100.80	10.32	2.58	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	99.62	9.41	2.27	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	118.16	17.32	4.07	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	168.67	25.53	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	226.08	18.43	7.56	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	289.59	77.15	5.56	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	123.93	25.64	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	95.45	23.63	2.06	0.72
mesothelioma cell line:Mero-25	10850-111F4	170.90	47.66	1.36	1.13
mesothelioma cell line:Mero-41	10851-111F5	291.17	81.65	6.85	1.71
mesothelioma cell line:Mero-48a	10852-111F6	304.25	105.18	8.19	1.77
mesothelioma cell line:Mero-82	10853-111F7	221.81	74.90	9.20	2.10
mesothelioma cell line:Mero-83	10854-111F8	240.52	49.70	4.09	1.19
mesothelioma cell line:Mero-84	10855-111F9	311.16	79.37	5.31	2.53
mesothelioma cell line:Mero-95	10856-111G1	327.33	88.61	8.28	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	314.07	110.16	9.77	1.49
mesothelioma cell line:NCI-H226	10846-111E9	226.78	85.07	7.96	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	240.86	40.31	5.47	1.71
mesothelioma cell line:NCI-H28	10845-111E8	161.33	37.15	3.56	1.27
mesothelioma cell line:No36	10857-111G2	129.83	21.86	3.59	0.65
mesothelioma cell line:ONE58	10858-111G3	99.17	18.70	2.71	1.08
migratory langerhans cells, donor1	11901-125F2	68.32	7.68	0.77	0.58
migratory langerhans cells, donor2	11902-125F3	79.38	8.18	0.49	0.61
migratory langerhans cells, donor3	11903-125F4	78.79	10.05	0.54	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	128.31	15.67	1.63	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	81.60	28.82	5.30	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	255.93	56.67	3.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	39.58	4.19	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	106.44	17.00	1.48	0.55
myeloma cell line:PCM6	10474-106I6	53.17	4.74	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	99.94	17.25	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	92.19	14.32	1.96	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	111.76	8.02	1.23	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	103.40	8.53	0.96	0.29
nasal epithelial cells, donor2	12227-129F4	107.64	16.56	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	175.08	59.82	4.83	0.46
neuroblastoma cell line:NB-1	10539-107G8	181.66	36.86	5.05	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	245.69	59.89	3.59	2.11
neuroblastoma cell line:NH-12	10555-107I6	137.90	26.28	2.24	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	93.23	18.98	2.14	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	634.95	172.48	21.06	6.18
neuroectodermal tumor cell line:TASK1	10774-110F9	129.01	19.92	3.02	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	87.74	6.36	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	196.96	36.46	2.13	0.53
neutrophil PMN, donor1	12133-128D9	119.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	174.19	48.54	1.35	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	135.29	11.21	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	187.23	21.48	3.21	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	305.60	47.56	6.83	3.42
nucleus accumbens, adult, pool1	10037-101F1	116.99	15.37	2.91	0.37
occipital cortex - adult, donor10196	10172-103C1	59.75	41.21	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	198.05	26.57	7.25	1.61
occipital cortex, newborn, donor10223	10355-105E4	85.89	24.38	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	95.78	10.23	4.20	0.79
occipital lobe, fetal, donor1	10073-102A1	108.56	17.59	2.57	0.43
occipital pole, adult, pool1	10036-101E9	101.00	12.85	2.52	0.47
olfactory region, adult	10195-103E6	113.68	14.90	1.91	1.15
optic nerve, donor1	10277-104E7	230.12	38.02	6.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	112.43	9.45	2.85	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	83.94	4.53	0.96	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	95.16	8.30	1.52	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	131.68	31.53	3.00	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	579.41	213.71	23.52	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	200.88	39.24	2.80	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	73.58	10.60	1.06	0.00
ovary, adult, pool1	10020-101D2	169.99	25.68	3.93	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	196.52	57.01	10.63	1.65
pancreas, adult, donor1	10049-101G4	137.33	14.11	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	98.68	9.78	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	459.78	192.50	15.84	10.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	344.91	83.62	9.93	1.66
paracentral gyrus, adult, pool1	10035-101E8	95.37	12.17	2.29	0.73
parietal cortex, adult, donor10258	10373-105G4	69.00	14.68	3.67	0.73
parietal lobe - adult, donor10196	10171-103B9	96.87	15.05	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	131.97	18.53	2.28	1.71
parietal lobe, adult, pool1	10034-101E7	111.12	13.48	2.03	0.26
parietal lobe, fetal, donor1	10072-101I9	101.83	15.52	2.91	1.94
parietal lobe, newborn, donor10223	10356-105E5	80.01	22.81	2.62	0.75
parotid gland, adult	10199-103F1	172.05	24.67	1.85	2.47
penis, adult	10200-103F2	113.87	24.71	3.22	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1006.10	220.71	32.54	7.62
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	331.89	63.96	9.18	1.60
pineal gland - adult, donor10196	10179-103C8	55.47	12.90	2.58	0.65
pineal gland, adult, donor10252	10160-103A7	82.32	15.40	4.15	0.00
pineal gland, adult, donor10258	10377-105G8	65.84	10.66	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	112.31	7.08	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	144.89	10.42	3.13	0.52
pituitary gland, adult, donor10258	10378-105G9	102.15	10.21	0.00	0.00
placenta, adult, pool1	10021-101D3	375.83	46.55	7.85	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	37.21	4.37	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	265.05	44.51	4.05	1.40
pons, adult, pool1	10033-101E6	124.80	19.45	3.96	0.17
postcentral gyrus, adult, pool1	10032-101E5	94.93	13.16	2.79	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	77.38	16.73	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	46.94	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	480.10	106.33	18.21	3.50
prostate cancer cell line:PC-3	10439-106E7	422.54	125.24	12.16	2.54
prostate, adult, pool1	10022-101D4	151.00	19.23	2.90	0.54
putamen, adult, donor10196	10176-103C5	103.40	15.58	5.19	0.71
putamen, adult, donor10252	10152-102I8	105.88	13.73	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	65.57	19.67	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	91.57	14.26	1.45	0.72
putamen, newborn, donor10223	10365-105F5	130.44	30.74	5.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	277.84	38.11	4.36	0.87
rectum, fetal, donor1	10067-101I4	175.27	27.82	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	262.24	87.98	5.72	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	504.51	78.29	8.28	3.31
retina, adult, pool1	10030-101E3	222.95	39.06	4.17	0.80
retinoblastoma cell line:Y79	10475-106I7	102.88	20.00	2.60	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	50.65	2.83	0.98	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	127.95	15.18	1.97	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	176.58	23.49	3.03	0.76
salivary acinar cells, donor1	11771-123I7	89.67	11.98	3.08	0.65
salivary acinar cells, donor2	11772-123I8	113.45	14.59	2.07	0.69
salivary acinar cells, donor3	11773-123I9	136.38	22.51	2.65	0.00
salivary gland, adult, pool1	10093-102C3	173.87	23.45	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	124.61	15.85	4.30	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	122.37	14.81	3.06	0.71
seminal vesicle, adult	10201-103F3	138.62	14.81	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	169.08	64.38	8.02	3.64
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	245.59	86.56	9.31	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	175.62	52.18	4.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	400.95	128.14	9.54	2.82
signet ring carcinoma cell line:Kato III	10436-106E4	197.96	46.64	2.54	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	101.28	11.61	1.55	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	61.00	15.61	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	99.31	23.99	2.16	0.12
skeletal muscle, fetal, donor1	10066-101I3	86.43	22.11	2.01	0.00
skin, adult, donor1	10074-102A2	108.56	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	140.76	15.78	2.52	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	112.40	15.34	4.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	117.89	34.36	2.52	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	148.03	9.25	2.51	1.54
small cell lung carcinoma cell line:LK-2	10541-107H1	181.97	42.53	2.31	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	90.88	6.43	0.97	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	269.35	56.22	2.83	0.87
small intestine, adult, pool1	10024-101D6	319.27	55.42	5.14	0.72
small intestine, fetal, donor1	10064-101I1	134.15	19.16	0.98	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	201.06	32.31	0.51	2.56
smooth muscle, adult, pool1	10048-101G3	150.16	17.06	3.36	1.81
somatostatinoma cell line:QGP-1	10781-110G7	135.08	17.96	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	203.71	28.91	5.51	2.06
spinal cord, adult, donor10252	10159-103A6	236.56	22.47	3.15	1.97
spinal cord, adult, donor10258	10369-105F9	190.94	31.13	3.46	0.00
spinal cord, fetal, donor1	10056-101H2	249.42	39.03	6.10	2.44
spinal cord, newborn, donor10223	10359-105E8	240.17	51.89	9.18	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	292.59	63.92	7.47	1.79
spleen, adult, pool1	10025-101D7	120.60	31.06	3.52	0.77
spleen, fetal, pool1	10044-101F8	144.29	32.26	4.21	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	56.41	5.59	1.14	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	76.71	3.99	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	182.06	23.06	3.84	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	109.07	24.24	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	161.30	30.05	4.05	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	45.33	4.66	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	137.92	20.73	3.38	0.42
stomach, fetal, donor1	10062-101H8	273.40	52.33	5.34	0.00
submaxillary gland, adult	10202-103F4	132.74	14.81	4.56	3.99
substantia nigra - adult, donor10196	10178-103C7	271.37	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	271.47	34.48	5.19	1.45
substantia nigra, adult, donor10258	10371-105G2	152.59	25.86	5.17	0.00
substantia nigra, newborn, donor10223	10358-105E7	290.40	46.63	9.19	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	123.12	17.88	3.90	0.92
temporal lobe, adult, pool1	10031-101E4	115.29	13.48	3.14	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	101.14	16.38	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	106.81	21.10	2.20	0.44
tenocyte, donor1	11763-123H8	292.20	54.46	6.28	2.79
tenocyte, donor2	11765-123I1	405.16	115.60	12.21	3.43
tenocyte, donor3	11768-123I4	232.04	38.18	9.27	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	177.61	28.72	4.42	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	102.66	14.03	2.16	0.77
teratocarcinoma cell line:PA-1	10807-111A6	103.06	12.55	1.39	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	135.20	27.80	4.19	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	146.73	32.14	1.13	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	87.69	19.09	2.62	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	179.14	74.59	6.84	3.91
testis, adult, pool1	10026-101D8	180.06	35.43	7.19	0.86
testis, adult, pool2	10096-102C6	189.91	40.15	11.28	4.51
thalamus - adult, donor10196	10168-103B6	220.80	23.18	7.73	2.21
thalamus, adult, donor10252	10154-103A1	255.37	31.41	5.00	2.34
thalamus, adult, donor10258, tech_rep1	10370-105G1	244.80	44.65	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	136.03	18.28	6.09	0.33
thalamus, newborn, donor10223	10366-105F6	106.43	18.99	2.30	0.00
throat, adult	10209-103G2	101.37	14.98	1.75	0.75
throat, fetal, donor1	10061-101H7	159.06	20.11	3.35	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	68.16	6.36	0.40	0.20
thymus, adult, pool1	10027-101D9	78.74	9.15	1.69	0.50
thymus, fetal, pool1	10043-101F7	116.48	16.21	1.56	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	150.38	49.33	4.52	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	207.44	80.32	7.40	1.12
thyroid, adult, pool1	10028-101E1	250.64	41.34	2.89	0.84
thyroid, fetal, donor1	10060-101H6	205.39	23.73	3.95	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	117.03	24.64	0.00	0.00
tongue, adult	10203-103F5	80.70	11.16	0.70	1.63
tongue, fetal, donor1	10059-101H5	117.44	19.31	5.12	0.79
tonsil, adult, pool1	10047-101G2	110.69	16.93	1.80	0.50
trachea, adult, pool1	10029-101E2	187.65	33.13	3.44	0.90
trachea, fetal, donor1	10058-101H4	155.42	25.01	3.08	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	153.40	21.97	3.54	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	373.45	122.69	11.75	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	176.43	19.43	2.82	1.57
tridermal teratoma cell line:HGRT	10694-109G1	195.96	32.34	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	137.56	24.46	2.20	0.08
umbilical cord, fetal, donor1	10057-101H3	175.27	43.82	2.09	0.00
uterus, adult, pool1	10100-102D1	227.79	39.07	4.61	1.19
uterus, fetal, donor1	10055-101H1	149.48	24.06	2.56	1.02
vagina, adult	10204-103F6	189.34	27.14	3.23	1.29
vein, adult	10191-103E2	91.41	14.69	2.85	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.91	3.74	0.53	0.27